bacteriophag
specif
antagonist
bacteri
host
viral
entiti
attract
grow
interest
optim
vaccin
deliveri
vehicl
phage
wellmatch
vaccin
design
due
highli
stabl
harsh
environment
condit
simpl
inexpens
larg
scale
product
potent
adjuv
capac
phage
vaccin
effici
immunostimulatori
effect
present
high
safeti
profil
virus
made
constant
relationship
mammalian
bodi
longstand
evolutionari
period
birth
phage
display
technolog
turn
point
develop
phagebas
vaccin
phage
display
vaccin
made
express
multipl
copi
antigen
surfac
immunogen
phage
particl
therebi
elicit
power
effect
immun
respons
also
abil
produc
combinatori
peptid
librari
highli
divers
pool
random
ligand
transform
phage
display
straightforward
versatil
high
throughput
screen
methodolog
identif
potenti
vaccin
candid
differ
diseas
particular
microbi
infect
librari
conveni
screen
affin
selectionbas
strategi
call
biopan
wide
varieti
target
select
mimotop
high
antigen
immunogen
also
pan
antiserum
convalesc
individu
recogn
novel
peptidomimet
pathogenrel
epitop
phage
display
repres
enorm
promis
find
new
strategi
vaccin
discoveri
product
current
breakthrough
promis
brilliant
futur
develop
differ
phagebas
vaccin
platform
virus
biochem
complex
made
genom
proteom
materi
physic
chemic
biolog
characterist
associ
structur
function
biolog
entiti
specifi
genet
sequenc
virus
infect
host
recogn
specif
receptor
surfac
host
cell
subsequ
transfer
genet
inform
cell
deliv
viral
genom
hijack
host
metabol
order
produc
virion
therebi
propag
viral
popul
within
recent
decad
consider
bodi
data
accumul
regard
molecular
basi
structur
function
featur
virus
find
led
paradigm
shift
understand
virus
diseasecaus
pathogen
healthgiv
biomed
tool
discoveri
bacteriophag
caus
surpsrisingli
dramat
increas
exploit
virus
variou
scientif
research
territori
bacteriophag
colloqui
phage
virus
infect
bacteri
cell
prokaryot
virus
known
success
life
form
earth
abund
genet
divers
higher
organ
number
phage
natur
estim
particl
nevertheless
recent
metagenom
studi
reveal
two
third
gene
sequenc
identifi
phage
isol
environment
sampl
novel
homolog
equival
databas
therefor
seem
current
knowledg
phage
divers
repres
tip
iceberg
phage
histori
initi
centuri
ago
felix
dherel
discov
power
viral
agent
cure
pathogen
bacteri
infect
therapeut
modal
call
phage
therapi
wane
rise
antibiot
era
howev
phage
continu
serv
favor
model
organ
experiment
system
develop
broad
array
molecular
tool
contribut
decod
mani
fundament
mysteri
biolog
numer
line
progress
inspir
phage
research
laid
foundat
new
disciplin
known
molecular
biolog
nowaday
intract
problem
trigger
everincreas
number
antibioticresist
bacteri
speci
driven
renaiss
interest
decadeslongneglect
field
phage
therapi
phage
research
repres
dynam
develop
field
continu
expand
scope
onecenturylong
histori
phage
studi
wit
ongo
breakthrough
provid
new
perspect
biomed
applic
viral
agent
current
phage
applic
cover
wide
varieti
area
includ
studi
proteinprotein
interact
antivir
research
anticanc
research
biosensor
design
develop
target
gene
drug
deliveri
platform
nanotechnolog
mention
vaccin
develop
one
import
applic
phage
display
receiv
huge
attent
recent
year
current
articl
discuss
potenti
phage
vaccin
deliveri
vehicl
phage
exploit
vaccin
deliveri
two
format
phage
dna
phage
display
vaccin
howev
largest
contribut
phage
vaccin
design
aris
phage
display
technolog
therefor
main
focu
phage
display
methodolog
applic
vaccin
design
regard
high
throughtput
screen
phage
combinatori
librari
affin
select
mimotop
identif
particularli
address
introduct
phage
display
technolog
may
consid
turn
point
histori
phage
research
conceptu
phage
display
adapt
basic
principl
genet
engin
combinatori
chemistri
launch
techniqu
mark
work
smith
colleagu
first
describ
display
foreign
polypeptid
surfac
filament
phage
particl
phage
display
exogen
dna
insert
specif
site
nucleotid
sequenc
encod
one
phage
coat
protein
phage
particl
infect
bacteri
host
express
gene
guest
amino
acid
encod
foreign
dna
express
part
relev
coat
protein
consequ
fusion
protein
display
expos
surfac
phage
virion
fig
guest
residu
fusion
protein
abl
interact
wide
varieti
extern
target
molecul
power
phage
display
technolog
result
abil
establish
physic
connect
phenotyp
display
peptid
genotyp
dna
sequenc
encod
display
peptid
phenotypegenotyp
link
form
cornerston
phage
display
methodolog
make
possibl
research
isol
targetavid
ligand
display
phage
one
hallmark
characterist
phage
display
technolog
capac
produc
larg
librari
fig
schemat
represent
phage
display
clone
foreign
dna
gene
encod
one
phage
coat
protein
lead
express
guest
amino
acid
sequenc
part
relev
coat
protein
phage
surfac
phage
display
display
peptid
phenotyp
encod
nucleotid
sequenc
genotyp
physic
link
togeth
individu
phage
particl
peptid
innov
develop
turn
phage
display
fast
reliabl
high
throughput
screen
methodolog
therefor
mani
use
function
peptid
desir
characterist
select
straightforward
effect
manner
construct
phage
display
librari
highli
divers
pool
random
oligonucleotid
sequenc
splice
one
phage
coat
protein
clone
larg
quantiti
oligonucleotid
fragment
phage
genom
phage
librari
may
harbor
million
sometim
billion
uniqu
distinct
display
peptid
ligand
fact
phage
virion
librari
display
individu
type
guest
peptid
surfac
howev
entir
librari
contain
huge
number
peptid
sinc
virion
act
independ
vector
capabl
infect
bacteria
phage
particl
select
librari
display
peptid
grown
propag
separ
host
cell
phage
display
librari
exhibit
sever
benefit
compar
type
screen
system
phage
particl
rather
small
estim
particl
may
present
ml
solut
small
size
phage
virion
allow
research
screen
larger
number
differ
particl
round
accordingli
higher
number
viral
particl
check
obtain
promis
binder
strongest
affin
target
easi
manipul
safeti
low
cost
propag
access
numer
commerci
avail
kit
advantag
associ
phage
display
librari
screen
purpos
furthermor
one
import
factor
contribut
widespread
applic
phage
display
conveni
librari
screen
select
targetspecif
binder
context
vaccin
develop
peptidebas
phage
display
librari
fall
two
main
categori
natur
peptid
librari
npl
random
peptid
librari
rpl
establish
npl
randomli
fragment
dna
deriv
genet
materi
organ
interest
incorpor
phage
genom
procedur
appli
fragment
obtain
genom
pathogen
microb
virus
bacteria
etc
thu
phage
particl
npl
display
surfac
fragment
natur
protein
rpl
construct
clone
synthet
random
degener
oligonucleotid
insert
phage
genom
compar
rpl
npl
like
mount
antibodi
respons
crossreact
nativ
intact
pathogen
howev
npl
suffer
major
limit
vast
major
clone
librari
nonfunct
contrast
rpl
univers
natur
result
construct
mode
even
peptid
found
within
antigen
intact
pathogen
display
surfac
librari
phage
librari
extend
markedli
rang
epitop
display
phage
virion
current
random
peptid
librari
known
frequent
use
type
phage
display
librari
use
extens
identifi
antigen
epitop
biopan
screen
combinatori
phage
display
librari
sinc
birth
phage
display
librari
screen
wide
varieti
target
first
purifi
biomolecul
like
receptor
antibodi
etc
use
target
howev
subsequ
year
phage
display
select
also
serv
isol
peptid
could
bind
complex
biolog
target
context
whole
cell
cultur
live
anim
exploit
target
therefor
ligand
obtain
could
bind
cell
surfac
receptor
home
vasculatur
specif
tissu
even
nonbiolog
element
semiconductor
also
found
applic
screen
target
phage
display
librari
screen
phage
display
librari
enrich
peptid
specif
bind
target
interest
perform
affin
selectionbas
strategi
call
biopan
fig
biopan
popul
phage
particl
includ
librari
random
peptid
incub
target
specifi
period
time
target
expos
seri
stringent
wash
step
phage
whose
display
peptid
bind
target
captur
wherea
unbound
weaklybound
phage
remov
interact
phage
elut
util
strategi
break
chemic
bond
target
display
peptid
without
compromis
phage
infect
alter
ph
ad
compet
ligand
appli
denatur
agent
use
proteolyt
enzym
approach
commonli
exploit
releas
retriev
targetbound
phage
method
use
virion
recoveri
phage
particl
extrem
stabl
harsh
condit
recov
phage
propag
infect
bacteri
host
cell
although
abovement
step
enrich
phage
particl
high
affin
target
librari
still
rel
heterogen
result
amplifi
pool
target
binder
need
expos
target
anoth
sever
round
typic
three
five
round
affin
select
suffic
reach
moststrongli
bind
ligand
final
targetspecif
binder
identifi
dna
sequenc
select
phage
round
biopan
stringenc
select
intensifi
progress
increas
number
durat
wash
order
isol
phage
clone
highest
affin
toward
target
biopan
procedur
undertaken
differ
format
straightforward
method
biopan
immobil
target
solid
support
multiwel
microtit
plate
polystyren
tube
nitrocellulos
surfac
monolith
column
immobil
solid
phase
may
achiev
either
direct
attach
target
surfac
solid
support
biotinyl
target
immobil
streptavidinco
surfac
last
sever
year
novel
type
phage
display
screen
solid
surfac
develop
select
scheme
ration
design
peptid
array
librari
synthes
function
cellulos
membran
fulli
autom
robot
system
peptid
librari
incub
fluoresc
label
cell
cell
fluoresc
use
detect
peptidetarget
cell
interact
peptid
array
whole
cell
bind
assay
use
success
isol
peptid
bind
specif
breast
cancer
cell
howev
methodolog
use
independ
complementari
convent
phage
display
optim
origin
select
target
cellbind
peptid
altern
target
immobil
solid
support
biopan
also
carri
solut
phase
screen
procedur
librari
react
target
solut
phagetarget
complex
affin
captur
onto
affin
matrix
specif
target
sort
affin
tag
target
need
affin
captur
occur
exampl
target
protein
glutathion
stransferas
gst
maltosebind
protein
mbp
polyhistidin
affin
tag
phagetarget
complex
captur
glutathion
amylos
nickel
bead
respect
also
protein
protein
g
bead
appli
captur
antibodi
target
solut
biopan
offer
advantag
solid
phase
screen
includ
enhanc
access
targetassoci
ligand
bind
site
librari
avoid
partial
denatur
target
solid
plastic
surfac
requir
extrem
less
number
target
molecul
experi
recent
new
approach
use
affin
select
phagedisplay
peptid
bind
solubl
protein
target
method
random
peptid
librari
incub
target
protein
affin
captur
onto
protein
g
magnet
bead
follow
transfer
phagemagnet
bead
conjug
organ
solut
remov
unbound
phage
recoveri
targetbound
phage
perform
centrifug
methodolog
appli
concept
organ
phase
separ
affin
select
phage
display
librari
call
magnet
bead
via
organ
phase
separ
mop
mop
demonstr
present
high
efficaci
select
binder
fcfusion
construct
improv
isol
specif
binder
solubl
protein
target
could
enrich
convent
biopan
gener
exploit
paramagnet
bead
target
immobil
bring
benefit
phage
display
librari
screen
includ
enhanc
surfac
area
bind
improv
conveni
thorough
wash
step
appropri
orient
bind
domain
target
molecul
anoth
interest
approach
biopan
use
magnet
nanoparticl
strategi
biopan
accomplish
conjug
target
molecul
onto
surfac
magnet
nanoparticl
condit
magnet
forc
may
appli
separ
fig
biopan
identif
targetspecif
phagedisplay
peptid
incub
random
peptid
phage
display
librari
target
follow
sequenti
multipl
wash
step
remov
unbound
phage
recoveri
targetbound
phage
amplif
bacteri
infect
step
repeat
round
final
select
phage
clone
display
peptid
highest
affin
toward
target
identifi
dna
sequenc
phagetarget
complex
although
process
target
antigen
conjug
tediou
timeconsum
abil
take
advantag
differ
chemic
enzymat
conjug
method
made
easier
use
semiautom
biopan
platform
semiautom
magnet
biopan
base
magnet
nanoparticl
allow
target
bind
effect
surfac
nanoparticl
enhanc
access
target
phage
particl
case
vivo
pan
select
procedur
taken
new
level
sophist
screen
methodolog
peptid
select
overcom
variou
inher
biolog
barrier
present
vivo
environ
eg
stabil
serum
cellular
access
etc
reach
target
vivo
approach
proven
larg
sucees
discoveri
numer
tissuespecif
home
peptid
also
appli
identifi
peptid
home
varieti
cancer
tissu
vivo
pan
phage
librari
administ
intraven
usual
tail
vein
mous
allow
circul
certain
time
period
anim
sacrif
desir
organ
tissu
extract
homogen
salin
solut
wash
remov
unbound
nonspecificallybound
phage
clone
typic
mediat
via
perfus
left
ventricl
organor
tissueassoci
phage
amplifi
bacteri
infect
inject
anoth
anim
sever
round
target
peptid
motif
specif
organ
identifi
although
phage
librari
tend
distribut
nonspecif
throughout
entir
anim
bodi
phage
specif
peptid
display
surfac
home
particular
tissu
ligand
select
vitro
vivo
bind
target
shoud
check
term
specif
valid
phage
specif
select
bind
target
vitro
vivo
varieti
method
use
immunostain
antiphag
antibodi
immunocytochemistri
icc
immunohistochemistri
ihc
techniqu
cellular
enzymelink
immunosorb
assay
elsa
competit
assay
use
free
synthet
peptid
vivo
imag
via
fluoresc
radioact
label
select
phage
synthet
produc
display
peptid
etc
phage
display
introduc
effici
altern
hybridoma
technolog
gener
therapeut
relev
antibodi
antibodi
phage
display
apd
provid
opportun
design
construct
larg
librari
antibodi
fragment
express
antibodi
surfac
phage
particl
repres
power
platform
isol
monoclon
antibodi
mab
desir
bind
characterist
serv
diagnosi
immunotherapi
variou
disord
especi
infecti
diseas
accord
sourc
antibodyencod
sequenc
phage
antibodi
librari
pal
divid
two
main
type
natur
synthet
librari
natur
pal
consist
rearrang
v
gene
repertoir
immun
nonimmun
donor
type
antibodi
librari
construct
differ
speci
includ
human
nonhuman
primat
mous
chicken
sheep
camel
cattl
immun
librari
consid
use
type
pal
infecti
diseas
construct
immun
donor
typic
exploit
obtain
antibodi
particular
target
antigen
eg
infecti
viral
bacteri
agent
great
advantag
immun
pal
v
gene
harbor
hypermut
affin
matur
though
toxic
antigen
ethic
issu
make
imposs
immun
human
subject
toxic
immunosuppress
lifethreaten
antigen
immun
possibl
ethic
impractic
construct
nonimmun
pal
altern
librari
gener
rearrang
v
gene
repertoir
b
cell
deriv
healthi
nonimmun
donor
accordingli
ethic
issu
regard
activ
immun
human
anim
avoid
also
specif
antibodi
nonimmunogen
toxic
antigen
also
obtain
howev
isol
antibodi
gener
show
low
affin
emphas
need
improv
bind
affin
select
antibodi
use
affin
matur
vitro
unlik
natur
pal
repres
natur
occur
divers
antibodi
repertoir
synthet
pal
harbor
artifici
divers
v
gene
segment
pal
v
gene
reconstruct
vitro
partial
semisynthet
pal
complet
fulli
synthet
pal
vitro
reconstruct
v
gene
made
via
random
complementar
determin
region
cdr
sourc
v
gene
introduc
divers
semisynthet
pal
might
unrearrang
germlin
v
gene
rearrang
v
gene
immun
andor
donor
singl
multipl
framework
scaffold
antibodi
random
cdr
particular
frequent
use
construct
semisynthet
pal
known
divers
loop
among
six
cdr
human
antibodi
term
length
sequenc
fulli
synthet
pal
construct
use
human
antibodi
framework
random
cdr
cassett
product
librari
base
silico
design
de
novo
synthesi
human
combinatori
antibodi
librari
hucal
inspir
exampl
fulli
synthet
pal
gener
analysi
sequenc
structur
framework
cdr
loop
region
librari
nucleotid
random
introduc
vh
region
differ
synthet
master
framework
fulli
synthet
pal
current
investig
improv
order
achiev
antibodi
favor
clinic
properti
adjust
aim
optim
synthet
bind
site
fine
tune
affin
size
valenc
well
minim
number
cell
epitop
larg
size
fulllength
mab
appear
major
challeng
achiev
desir
clinic
outcom
circumv
limit
fullsiz
mab
smaller
antibodi
format
improv
pharmacokinet
pharmacodynam
properti
develop
includ
fragment
antigen
bind
fab
singlechain
variabl
fragment
scfv
singl
domain
antibodi
sdab
interestingli
novel
categori
antibodi
fragment
call
nanobdi
current
known
smallest
recombin
antigen
bind
domain
kda
full
function
produc
emerg
nanobodi
goe
back
two
decad
ago
earli
discov
serendipit
around
fifti
percent
humor
immun
respons
camelida
famili
provid
uniqu
repertoir
fulli
function
antibodi
contain
heavi
chain
antibodi
known
heavi
chain
antibodi
hcab
strike
contrast
wellestablish
structur
igg
mammal
compos
two
ident
heavi
chain
two
ident
light
chain
nanobodi
vhh
variabl
domain
hcab
respons
antigen
bind
featur
nanobodi
receiv
grow
interest
promis
class
recombin
clinic
valuabl
antibodi
fragment
compar
convent
antibodi
nanobodi
hydrophil
structur
lead
high
solubl
also
convex
surfac
long
cdr
enabl
recogn
epitop
cryptic
inaccess
convent
antibodi
fragment
eg
epitop
catalyt
site
enzym
due
easi
molecular
manipul
nanobodi
excel
product
multival
antigen
bind
construct
nanobodi
close
relat
human
vh
sequenc
show
low
immunogen
potenti
nanobodi
serv
variou
infecti
agent
immunodiagnost
immunotherapeut
purpos
consist
nanobodi
demonstr
repres
potenti
applic
antitrypanosoma
agent
trypanosoma
parasit
escap
host
immun
system
via
expos
hypervari
epitop
variant
surfac
glycoprotein
vsg
conserv
epitop
vsg
cryptic
less
immunogen
potenti
immun
camelu
dromedariu
antigen
vsg
led
identif
nanobodi
capabl
target
conserv
asnlink
carbohydr
vsg
also
vsgspecif
nanobodi
conjug
exhibit
present
capac
diagnost
tool
imunodetect
trypanasoma
furthermor
conjug
vgsspecif
nanobodi
truncat
apolipoprotein
abl
lyse
sensit
resist
trypanosoma
brucei
rhodesiens
caus
complet
elimin
parasit
acut
chronic
phase
challeng
infect
mous
model
sever
nanobodi
also
select
cell
surfac
protein
fungu
malassezia
furfur
nanobodi
highli
stabl
harsh
environment
condit
shampoo
formul
use
inhibit
growth
fungu
scalp
fungustarget
molecul
develop
antidandruff
drug
moreov
nanobodi
rotaviru
isol
stomach
acid
environ
indic
consider
reduct
occurr
rotavirusinduc
diarrhea
mous
model
anoth
line
research
nanobodi
demonstr
effici
immunodiagnost
immunotherapeut
agent
bacteri
toxin
nanobodi
specif
bind
lipopolysaccharid
lp
neisseria
meningitidi
inhibit
lp
attach
human
monocyt
thu
interf
subsequ
signal
induc
bacteri
bind
host
cell
also
differ
nanobodi
identifi
potenti
applic
immunodetect
cholera
toxin
staphylococc
enterotoxin
b
botulinum
neurotoxin
complex
toxicshock
syndrom
taken
togeth
therapeut
mab
exploit
target
moieti
develop
drug
deliveri
system
target
toward
infectioncaus
agent
importantli
therapeut
applic
phage
displayderiv
antibodi
base
immunolog
properti
might
occur
capac
antibodi
recogn
specif
epitop
target
pathogen
follow
gener
protect
immun
respons
elimin
pathogen
antibodi
block
activ
infecti
agent
neutral
pathogenderiv
toxin
trigger
phagocytosi
prevent
pathogen
attach
host
cell
diseasespecif
antibodi
librari
repres
enorm
potenti
product
monoclon
antibodi
particular
diseasecaus
agent
raxibacumab
palivizumab
exampl
palderiv
antibodi
exploit
immunotherapi
human
diseas
monoclon
antibodi
might
serv
prophylaxi
treatment
bacillu
anthraci
caus
agent
anthrax
respiratori
syncyti
viru
bronchiol
gener
pal
speed
process
gener
desir
antibodi
specif
antigen
faster
procedur
antibodi
product
prime
import
emerg
infecti
diseas
fact
pal
offer
huge
potenti
rapid
develop
therapeut
relev
antibodi
emerg
infecti
agent
high
concern
genet
modifi
invad
pathogen
emerg
condit
rise
new
infecti
diseas
particular
newlyarisen
viral
infect
pal
play
import
role
establish
effici
immunotherapeut
novel
pathogen
futur
sinc
palderiv
antibodi
typic
common
limit
anim
base
antibodi
toxic
agent
eg
pathogenderiv
toxin
even
live
cultur
diseas
pose
barrier
process
antibodi
gener
major
goal
vaccin
elicit
strong
immun
respons
could
lead
format
mainten
longlast
immun
previous
vaccin
research
focus
develop
prophylact
agent
pathogen
microb
howev
current
research
also
devot
effort
make
vaccin
differ
disord
especi
cancer
mani
vaccin
type
abl
initi
power
effect
immun
respons
larg
attribut
absenc
proper
deliveri
system
effici
activ
immun
system
therefor
develop
optim
deliveri
system
particular
import
type
vaccin
bacteriophag
attract
attent
vaccinologist
use
vaccin
deliveri
agent
immunogen
carrier
potenti
applic
develop
differ
vaccin
type
first
use
recombin
phage
immunogen
describ
de
la
cruz
et
al
clone
repeat
region
circumsporozoit
cp
protein
gene
plasmodium
falciparum
caus
parasit
malaria
one
minor
coat
protein
gene
filament
phage
show
recombin
phage
prepar
antigen
immunogen
rabbit
applic
vaccin
design
phage
particl
abl
deliv
cargo
target
cell
reason
take
brief
look
capac
phage
cargo
deliveri
eukaryot
cell
particular
cell
mammalian
origin
although
bacteriophag
virus
specif
infect
bacteri
cell
rang
convinc
evid
strongli
support
idea
prokaryot
virus
also
deliv
encod
gene
human
cell
first
discov
merril
et
al
found
exposur
human
fibroblast
cell
deriv
child
congenit
defici
enzym
uridyl
gpu
transferas
activ
phage
harbor
wildtyp
copi
transferas
gene
lead
induct
enzym
activ
within
recent
year
grow
bodi
inform
highlight
import
phage
gene
transfer
mammalian
cell
find
reinforc
notion
bacteriophag
use
novel
effici
categori
gene
deliveri
vehicl
gdv
introduct
variou
diagnost
therapeut
cargo
human
cell
develop
capac
phage
attribut
longstand
continu
evolutionari
relationship
virus
human
bodi
current
shown
phage
along
bacteri
host
form
major
part
natur
microflora
human
bodi
spite
capac
phage
virion
deliveri
payload
mammalian
cell
interest
note
one
discrimin
concept
interact
infect
notion
gain
signific
observ
phage
abl
interact
infect
multipli
mammalian
cell
formerli
though
phage
dna
prokaryot
origin
could
function
eukaryot
howev
becom
evid
phagederiv
gene
function
properli
mammalin
cell
practic
point
view
phagebas
vaccin
demonstr
caus
signific
side
effect
vivo
sever
line
evid
anim
impli
high
dose
intraven
administ
phage
yield
overt
toxic
fact
bacteriophag
infecti
human
could
act
pathogen
agent
bodi
authent
much
less
like
bind
human
cell
surfac
receptor
manner
trigger
intracellular
signal
transduct
pathway
result
downstream
toxic
effect
insid
cell
inhibit
phage
particl
abl
propag
eukaryot
cell
behav
inert
particul
entiti
applic
consid
much
safer
viral
vaccin
gener
phage
possess
sever
characterist
make
wellmatch
develop
vaccin
deliveri
platform
viral
particl
highli
stabl
divers
rang
harsh
environment
condit
adapt
inexpens
larg
scale
product
use
simpl
bacteriolog
media
requir
cell
cultur
system
manufactur
suffici
quantiti
phage
intrins
capabl
stimul
arm
immun
system
humor
cellmedi
immun
demonstr
strong
adjuv
abl
boost
immun
respons
antigen
present
togeth
phage
particl
immunostimulatori
effect
phagebas
vaccin
elimin
need
adjuv
frequent
administ
along
recombin
protein
synthet
peptid
improv
immun
respons
vaccin
thu
phage
use
altern
classic
carrier
protein
exampl
filament
phage
display
peptid
surfac
indic
gener
immun
respons
mice
potent
coupl
peptid
tradit
carrier
ovalbumin
one
import
factor
contribut
immunostimulatori
properti
adjuv
capac
phage
presenc
number
unmethyl
cpg
motif
genom
motif
account
activ
innat
immun
system
tolllik
receptor
tlr
function
phage
natur
adjuv
abrog
need
altern
adjuv
purif
conjug
vaccin
therefor
incorpor
phage
particl
formul
vaccin
candid
enorm
decreas
expens
produc
new
vaccin
increas
effici
due
particul
natur
phage
vaccin
taken
antigen
present
cell
apc
apc
engulf
phage
antigen
immunogen
determin
process
effici
present
phagemedi
antigen
major
histocomapt
complex
mhc
class
ii
pathway
mhcmediat
peptid
present
stimul
cellular
humor
immun
respons
reveal
phage
particul
antigen
activ
antibodi
product
via
mhc
class
ii
pathway
also
mount
cellmedi
immun
gain
access
mhc
class
pathway
although
vaccin
administr
subcutan
intramuscular
inject
widespread
administr
rout
phagebas
vaccin
stabl
gastrointestin
tract
thu
repres
potenti
use
oral
neverthesless
specul
risk
oral
administr
phage
infect
gut
microbiota
perturb
microbi
flora
bodi
circumv
problem
exploit
nonlyt
phage
might
better
strategi
nonlyt
phage
reduc
risk
destroy
natur
gut
bacteria
consist
notion
phage
vaccin
demonstr
produc
strong
immun
respons
mice
anim
vaccin
oral
rout
sever
studi
confirm
immunostimulatori
effect
phagebas
vaccin
use
oral
administr
although
histori
phage
research
flood
studi
address
interact
phage
bacteri
host
reveal
phage
particl
also
abl
interact
differ
mammalian
cell
particular
cell
immun
system
interact
mainli
involv
two
area
first
focus
immunogen
phage
particl
defin
capac
phage
elicit
specif
immun
respons
product
antiphag
antibodi
take
promin
place
issu
phage
immunogen
second
area
involv
immunomodulatori
activ
phage
particl
link
phage
nonspecif
effect
function
immun
cell
implic
innat
adapt
immun
respons
capac
phage
mount
vivo
humor
respons
serv
thirti
year
clinic
immunolog
effici
tool
evalu
helper
celldepend
antibodi
product
immunodefici
patient
differ
report
impli
phage
abl
induc
product
specif
antibodi
exampl
shown
enhanc
level
antibodi
specif
staphylococc
phage
found
individu
bacteri
infect
significantli
higher
noninfect
healthi
individu
signific
decreas
antibodi
titer
detect
infect
regress
interestingli
sera
nonimmun
subject
may
low
level
antiphag
antibodi
presenc
socal
natur
antibodi
believ
result
omnipres
phage
includ
differ
environ
expos
food
eat
normal
microflora
bodi
antiphag
antibodi
belong
categori
neutral
antibodi
capac
bind
viral
epitop
essenti
infect
host
cell
therefor
antiphag
antibodi
prevent
phage
infect
host
bacteri
cell
gener
magnitud
antiphag
humor
respons
appear
depend
differ
factor
phage
type
administr
rout
initi
statu
expos
individu
differ
studi
highlight
phagedisplay
peptid
abl
elicit
specif
antipeptid
humor
respons
context
phage
use
carrier
immunogen
epitop
obtain
infecti
agent
order
rais
antibodi
respons
specif
display
peptid
consist
two
peptid
epitop
circumsporozoit
protein
plasmodium
falciparum
call
display
filament
phage
abl
induc
specif
igg
antibodi
respons
mous
model
investig
show
immun
respons
celldepend
also
fd
phagedisplay
peptid
epitop
loop
surfac
glycoprotein
revers
transcriptas
human
immunodefici
viru
hiv
glycoprotein
g
human
respiratori
syncyti
viru
rsv
capabl
induc
product
high
titer
pathogenspecif
antibodi
confer
resist
infecti
agent
vaccin
anim
taken
togeth
observ
provid
strong
support
notion
peptid
epitop
display
surfac
phage
particl
repres
huge
potenti
use
effici
mean
focus
antibodi
respons
pathogenderiv
epitop
trigger
potent
pathogenspecif
humor
respons
phage
cellmedi
immun
respons
cell
known
play
import
role
effect
clearanc
virusinfect
cell
inhibit
growth
expans
tumor
cell
occur
via
cell
provid
cellular
arm
adapt
immun
pathogen
virus
capac
activ
potent
cytotox
lymphocyt
ctl
respons
utmost
import
defens
viral
infect
assum
import
featur
need
consid
develop
vaccin
platform
one
main
limit
vaccin
contain
nonliv
compon
lack
abil
reach
mhc
pathway
activ
ctl
respons
although
phagemedi
celldepend
immun
studi
less
antiphag
humor
respons
numer
line
evid
indic
phagedisplay
peptid
epitop
mount
effici
cellular
immun
respons
reveal
phage
particl
provid
mean
exogen
antigen
reach
mhc
class
pathway
fact
phage
display
epitop
tumor
associ
antigen
taa
viral
peptidesar
abl
present
epitop
highli
immunogen
form
elicit
strong
peptidespecif
ctl
respons
vitro
vivo
context
display
peptid
deriv
revers
transcriptas
fd
phage
led
prime
epitopespecif
ctl
respons
human
cell
line
also
mice
immun
epitopedisplay
phage
result
effici
specif
ctl
respons
innat
immun
refer
nonspecif
reaction
bodi
foreign
antigen
procedur
univers
pathogenassoci
molecular
pattern
pamp
recogn
differ
pattern
recognit
receptor
prr
express
defens
cell
host
prr
provid
immedi
respons
invad
pathogen
also
varieti
solubl
prr
blood
act
opsonin
trigger
complement
pathway
tlr
constitut
one
bestcharacter
import
class
prr
receptor
express
phagocyt
cell
play
signific
role
innat
immun
respons
includ
inflammatori
reaction
pamp
recognit
prr
activ
cell
releas
signal
molecul
cytokin
cytokin
act
messeng
stimul
activ
element
immun
system
activ
innat
immun
relat
inflammatori
reaction
occur
respons
presenc
foreign
antigen
bodi
reveal
pamp
recognit
subsequ
tlrmediat
activ
monocyt
macrophag
lead
elev
product
reactiv
oxygen
speci
ro
nitric
oxid
varieti
inflammationassoci
cytokin
varieti
studi
indic
phage
substanti
impact
product
variou
cytokin
effect
express
level
proinflammatori
antiinflammatori
cytokin
inject
fd
phage
found
increas
interferon
gamma
level
purifi
prepar
staphylococcu
aureu
phage
abl
induc
product
purifi
phage
prepar
inhibit
product
mitogeninduc
data
gather
experiment
phage
therapi
anim
exhibit
success
therapi
correct
enhanc
level
proinflammatori
cytokin
relat
bacteri
infect
also
treatment
burn
wound
infect
caus
klebsiella
pneumonia
associ
reduc
level
tumor
necrosi
factor
alpha
sera
lung
phageadminist
mice
major
part
inform
effect
phage
regul
level
differ
cytokin
obtain
phage
therapi
studi
hand
mani
unmethyl
cpg
motif
genom
phage
recogn
elicit
respons
lead
releas
numer
cytokin
reveal
cytokin
product
depend
sever
factor
importantli
phage
type
dictat
type
level
cytokin
produc
also
phage
therapi
studi
confirm
cytokin
product
depend
initi
respons
individu
exampl
patient
low
moder
level
serum
upregul
cytokin
patient
initi
high
serum
level
downregul
cytokin
follow
phage
therapi
phage
appli
differ
rout
link
togeth
specif
nonspecif
immun
respons
therebi
connect
innat
compon
immun
system
adapt
immun
phage
recognit
antiphag
antibodi
trigger
activ
serum
complement
pathway
complement
activ
contribut
activ
reticuloendotheli
system
re
phage
circul
blood
may
inactiv
re
macrophag
re
antiphag
antibodi
involv
clearanc
phage
particl
bodi
one
outcom
complement
activ
product
complement
cleavag
product
interact
divers
receptor
found
surfac
myeloid
lymphoid
stromal
cell
interact
provid
basi
regul
b
cellmedi
immun
respons
also
cpg
motif
found
phage
genom
also
capabl
connect
innat
adapt
immun
respons
capac
activ
antigenpres
cell
apc
exploit
phage
vaccin
deliveri
vehicl
divid
two
main
categori
includ
phage
dna
vaccin
phage
display
vaccin
fig
phage
dna
vaccin
antigencod
gene
clone
eukaryot
cassett
insert
phage
genom
eukaryot
cassett
contain
sequenc
essenti
proper
regul
gene
express
includ
promot
region
orf
open
read
frame
region
poli
tail
therefor
antigencod
gene
control
strong
promot
effici
regulatori
sequenc
amplif
bacteri
cell
whole
phage
particl
purifi
inject
host
immun
tool
unlik
standard
dna
vaccin
vaccineproduc
sequenc
protect
degrad
phage
coat
protein
therefor
vaccin
higher
stabil
administr
particular
oral
vaccin
storag
transport
compar
standard
plasmid
dna
vaccin
phage
dna
vaccin
demonstr
yield
better
result
lower
dose
vaccin
use
immun
differ
small
larg
anim
model
result
demonstr
induc
significantli
higher
longerlast
antibodi
respons
comparison
nake
dna
vaccin
even
purifi
recombin
protein
howev
import
contribut
phage
vaccin
develop
product
phage
display
vaccin
phagebas
antigen
deliveri
approach
gain
grow
interest
suggest
prospect
tool
area
vaccin
design
within
past
year
phage
display
vaccin
repres
promis
approach
vaccin
develop
phage
display
vaccin
foreign
antigen
display
phage
surfac
gener
achiev
express
antigen
interest
fusion
one
surfac
protein
virion
sinc
multipl
copi
desir
antigen
surfac
phage
particl
phagedisplay
vaccin
abl
provid
high
level
fig
phage
dna
vs
phage
display
vaccin
phage
dna
vaccin
eukaryot
gene
express
cassett
contain
antigen
sequenc
clone
phage
genom
therefor
antigen
express
control
eukaryotederiv
regulatori
sequenc
b
phage
display
vaccin
main
phagebas
strategi
vaccin
design
vaccin
sequenc
clone
phage
coat
protein
gene
therefor
antigen
amino
acid
express
fusion
coat
protein
phage
surfac
antigen
amino
acid
residu
readili
present
immun
system
antigen
exposur
immun
system
howev
display
antigen
epitop
properli
fold
function
conform
could
elicit
strong
immun
respons
signific
issu
deserv
attent
develop
phage
display
vaccin
sometim
rather
construct
transcript
fusion
coat
protein
phage
displi
vaccin
may
creat
conjug
antigen
substanc
phage
surfac
via
artifici
linker
exploit
strategi
construct
phage
display
vaccin
may
diversifi
rang
antigen
display
surfac
immunogen
phage
particl
howev
antigen
encod
phage
genom
strategi
thu
vaccin
construct
prepar
everi
time
need
strike
contrast
genet
approach
phage
virion
antigen
sequenc
genom
therefr
continu
produc
vaccin
construct
conveni
bacteri
amplif
need
repetit
attach
antigen
substanc
phage
surfac
differ
phage
use
display
antigen
phage
display
vaccin
platform
includ
lambda
even
rna
phage
appli
popular
platform
develop
vaccin
differ
patholog
includ
cancer
varieti
parasit
bacteri
infect
bodi
filament
phage
cover
copi
major
coat
protein
pviii
cap
end
five
copi
minor
coat
protein
includ
piii
pvi
pvii
pix
lambda
phage
anoth
import
system
develop
phage
display
vaccin
foreign
antigen
fuse
gpd
exist
copi
protein
phage
surfac
abil
display
high
copi
number
antigen
surfac
individu
phage
virion
highli
effect
trigger
appropri
immun
respons
compar
display
antigen
low
copi
number
fusion
product
antigengpd
shown
gener
neutral
antibodi
porcin
circoviru
infect
anoth
bacteriophag
repres
potenti
vaccin
platform
phage
two
highli
immunogen
protein
outer
surfac
call
soc
hoc
coat
protein
effect
serv
display
foreign
antigen
phage
surfac
domain
ideal
expos
fuse
epitop
structur
immun
system
adapt
display
peptid
variou
size
display
antigen
substanc
phage
antigen
commonli
fuse
carboxyl
end
capsid
protein
display
humanderiv
vascular
endotheli
growth
factor
vegf
capsid
phage
demonstr
produc
strong
immun
respons
cancer
cell
inhibit
growth
cancer
cell
inject
mic
lewi
lung
cancer
xenograft
tumor
bacteriophag
rna
genom
also
appli
develop
vaccin
qb
rna
virus
antigen
fuse
surfac
coat
protein
use
product
vaccin
drug
addict
hiv
infect
filament
phage
constitut
group
virus
abl
infect
gramneg
bacteria
f
plasmid
virus
belong
inovirida
famili
genu
inoviru
filament
phage
ff
class
includ
fd
gener
predomin
phage
display
vector
accordingli
popular
system
gener
phage
display
vaccin
rodshap
bacteri
virus
simplest
capsid
term
number
differ
protein
type
harbor
singlestrand
dna
genom
ideal
genet
engin
purpos
filament
phage
immunogen
tradit
carrier
protein
bovin
serum
albumin
bsa
keyhol
limpet
hemocyanin
klh
howev
contain
rel
endogen
b
cell
epitop
whose
presenc
may
divert
antibodi
respons
intend
target
might
ascrib
connect
filament
phage
human
bodi
long
evolutionari
period
phage
infect
escherichia
coli
commens
bacterium
resid
human
gut
capabl
live
human
bodi
filament
phage
evolv
protein
induc
lowlevel
antibodi
respons
fact
appli
mechanishm
evad
mucos
gener
antibodi
respons
exampl
piii
coat
protein
filament
phage
larg
enough
approxim
amino
acid
present
varieti
b
cell
cell
epitop
typic
peptid
display
surfac
phage
particl
demonstr
elicit
antibodi
product
experiment
anim
model
howev
depend
characterist
display
peptid
method
display
gener
piii
pviii
known
wide
use
coat
protein
filament
phage
display
exogen
amino
acid
sequenc
due
high
copi
number
pviii
wellmatch
display
peptid
small
protein
consid
effici
platform
display
larg
antigen
contrast
piii
low
copi
number
exploit
effect
display
larg
antigen
impli
copi
number
display
antigen
critic
factor
requir
much
consider
vaccin
develop
dispali
peptid
low
copi
number
piii
fusion
tend
gener
lower
immunogen
display
peptid
high
copi
number
pviii
fusion
low
copi
number
antigen
display
fusion
piii
may
pose
barrier
phage
display
vaccin
turn
vaccin
type
suboptim
choic
howev
pviii
provid
advantag
high
valenc
display
foreign
antigen
phage
surfac
line
peptidepviii
fusion
contain
mimotop
human
hepat
b
viru
surfac
antigen
hbsag
indic
produc
potent
antibodi
respons
mice
rabbit
compar
phagedisplay
mimotop
fusion
piii
fusion
human
h
ferritin
fusion
hepat
b
viru
hbv
core
peptid
synthes
multipl
antigen
peptid
carri
amino
acid
sequenc
mimotop
gener
copi
number
increas
display
peptid
made
possibl
recombin
fusion
protein
effici
accommod
pack
phage
surfac
reveal
peptid
abl
effect
mimic
epitop
structur
present
antigen
peptid
call
mimotop
one
promis
applic
phage
display
technolog
pan
rpl
specifi
target
identif
mimotop
mimotop
mimic
structur
antigen
epitop
offer
potenti
use
vaccin
candid
base
vaccin
research
screen
rpl
select
immunogen
mimic
capabl
elicit
power
antibodi
respons
vivo
peptid
sequenc
potenti
mimick
conform
antigen
epitop
success
isol
librari
screen
requir
analys
immunogen
antigen
properti
determin
mimotop
deriv
librari
known
potent
immunogen
antigen
consid
suitabl
candid
vaccin
product
mimotop
undergo
prevalid
step
procedur
mimotop
evalu
bioinformat
analys
experiment
assay
elisa
subsequ
best
select
phage
clone
eg
highest
reactiv
valu
elisa
assay
chosen
investig
ex
vivo
vivo
assess
either
select
phage
clone
synthet
mimotop
use
directli
anim
immun
use
phage
clone
immunogen
wildtyp
phage
may
exploit
control
phage
particl
harbor
protein
interact
host
immun
system
result
develop
nonspecif
immun
respons
nonspecif
respons
interfer
specif
immun
respons
induc
phagedisplay
mimotop
use
select
mimotop
animalbas
immunolog
test
one
help
strategi
take
advantag
repeat
peptid
sequenc
separ
spacer
aid
appropri
conform
arrang
origin
epitop
structur
repeat
select
immunolog
motif
make
possibl
mimic
phage
capsid
structur
piii
protein
sometim
bsa
conjug
peptid
sequenc
rais
immun
respons
immun
anim
either
phage
clone
display
mimotop
synthet
mimotop
anim
challeng
infect
target
pathogen
infect
anim
monitor
surviv
sever
week
usual
week
postchalleng
sacrif
blood
spleen
collect
use
analyz
humor
cellular
respons
humor
immun
respons
assess
measur
igg
isotyp
distribut
includ
igg
sera
immun
anim
elev
product
may
consid
evid
immun
respons
respect
investig
cellular
immun
respons
splenocyt
peripher
blood
mononuclear
cell
pbmc
cultur
product
level
varieti
cytokin
determin
cultur
supernat
differ
interleukin
ifnc
granulocyt
macrophag
colonystimul
factor
gmcsf
molecul
commonli
use
cytokin
product
analysi
enzymelink
immunospot
elispot
assay
known
wide
exploit
methodolog
monitor
cellmedi
immun
techniqu
adopt
detect
quantif
cytokinesecret
cell
anoth
approach
may
use
examin
protect
efficaci
mimotop
monitor
parasit
burden
liver
spleen
bone
marrow
lymph
node
immun
anim
within
severalweek
period
postinfect
signific
reduct
pathogen
load
tissu
may
present
efficaci
select
mimotop
effici
vaccin
one
advantag
provid
phage
display
librari
biopan
mimotop
identif
vaccin
product
abil
screen
rpl
polysaccharidespecif
antibodi
therefor
methodolog
might
use
obtain
peptidomimet
polysaccharid
select
scenario
particuar
import
product
novel
vaccin
encapsul
bacteria
polysaccharid
capsul
bacteria
often
possess
antigen
featur
set
rpl
exploit
isol
peptid
mimic
polysaccharid
capsul
neisseria
meningitidi
includ
serotyp
b
c
pathogen
bacterium
mimotop
identifi
serotyp
abl
mount
protect
antibodi
respons
murin
model
phage
display
methodolog
exploit
anoth
context
achiev
vaccin
candid
phage
display
librari
may
screen
specif
antiserum
recogn
novel
mimotop
situat
immun
serum
convalesc
individu
serv
target
biopan
thu
potenti
vaccin
candid
specif
diseas
isol
procedur
perform
without
prior
knowledg
characterist
protect
antigen
regard
screen
rpl
serum
deriv
individu
hbv
infect
led
identif
peptidomimet
viral
epitop
immun
anim
model
peptid
mimic
result
product
virusneutr
antibodi
approach
also
use
serum
sampl
cystic
fibrosi
cf
patient
pseudomona
aeruginosa
infect
led
identif
sever
antigen
encod
outer
membran
protein
secret
protein
bacterium
antigen
suggest
potenti
target
vaccin
gener
pseudomona
aeruginosa
infect
increas
chanc
isol
phagedisplay
peptid
high
affin
bind
diseasespecif
antibodi
phage
librari
first
expos
neg
screen
sera
noninfect
peopl
follow
posit
select
sera
infect
patient
strategi
use
isol
mimotop
parasit
brugia
malayi
one
caus
agent
lymphat
filariasi
sever
identifi
antigen
one
confer
protect
parasit
anim
challeng
infect
wide
varieti
pathogen
use
target
phage
display
select
biopan
thu
far
screen
phage
display
librari
appli
identifi
peptidomimet
vaccin
candid
numer
diseasecaus
infecti
agent
tabl
list
import
studi
phage
display
biopan
serv
identifi
mimotop
numer
pathogen
organ
mimotop
repres
potenti
applic
vaccin
formul
prevent
diseas
caus
pathogen
although
bacteriophag
phylogenet
fall
categori
virus
present
pictur
complet
differ
portrait
virus
phage
infect
agent
eukaryot
therefor
could
trigger
pathogenesi
human
bodi
inde
even
exploit
use
agent
prophylact
therapeut
purpos
phagebas
vaccin
serv
prevent
platform
battl
microbi
parasit
infect
also
find
util
therapeut
platform
combat
noninfecti
diseas
therapeut
applic
phagebas
vaccin
achiev
immunotherapi
base
har
innat
power
bodi
natur
defens
fight
diseas
manner
phageinspir
vaccin
direct
toward
treatment
cancer
neurodegen
disord
drug
addict
etc
bodi
convinc
evid
reinforc
notion
phage
abl
interact
releas
cargo
insid
mammalian
cell
thu
suggest
novel
genedrug
deliveri
vehicl
howev
phage
specif
antagonist
prokaryot
host
natur
capac
eukaryot
cargo
deliveri
remain
larg
limit
surfac
engin
phage
phage
display
dramat
improv
efficaci
viral
particl
deliveri
prophylact
diagnost
therapeut
cargo
eukaryot
host
strategi
alter
surfac
bind
properti
consequ
host
rang
phage
virion
via
capacit
interact
mammalian
cell
phage
display
technolog
made
revolut
biomed
applic
bacteriophag
actual
avibacterium
paraglinarum
bacterium
brucella
sp
bacterium
entamoeba
histolytica
ptotozoa
fasciola
hepatica
flatworm
hepat
viru
hav
viru
hepat
b
viru
hbv
viru
hepat
c
viru
hcv
viru
herp
simplex
viru
viru
human
trypanosoma
cruzi
protozoa
birth
versatil
methodolog
import
mileston
histori
phage
research
contribut
tremend
field
vaccin
develop
innov
techniqu
bring
opportun
express
wide
varieti
antigen
surfac
phage
particl
accordingli
phage
might
adopt
vaccin
deliveri
vehicl
phage
display
system
use
differ
phage
well
differ
protein
certain
phage
antigen
fuse
phage
coat
protein
sinc
sever
copi
coat
protein
present
phage
surfac
sometim
sever
hundr
thousand
copi
virion
carri
multipl
copi
antigen
interest
surfac
result
larg
amount
antigen
expos
bodi
immun
system
one
relev
contributori
factor
matur
phage
optim
vaccin
deliveri
system
imunostimulatori
characterist
potent
adjuv
capac
critic
signific
attribut
turn
phage
effici
immunogen
carrier
mount
humor
cellmedi
immun
compar
viral
group
phage
interestingli
offer
far
higher
degre
vivo
safeti
make
wellmatch
tool
translat
bench
bedsid
also
rise
combinatori
peptid
librari
shine
star
firmament
phage
applic
random
librari
rich
collect
peptid
ligand
transform
phage
display
high
throughput
screen
approach
huge
potenti
select
specif
ligand
exist
exhaust
reservoir
peptid
enabl
vaccin
research
find
potenti
mimotop
high
antigen
immunogen
phage
display
librari
rare
function
mimotop
among
larg
popul
nonfunct
peptid
assum
gem
junk
whose
capac
mimick
antigen
structur
use
immunostimul
anoth
contribut
phage
display
field
vaccin
product
potenti
develop
hybrid
phage
vaccin
vaccin
type
construct
combin
two
approach
phage
dna
vaccin
phage
display
vaccin
combinatori
platform
phage
particl
carri
foreign
antigenencod
gene
genom
time
display
peptid
protein
surfac
display
peptid
protein
may
target
molecul
exampl
select
biopan
specif
bind
affin
toward
apc
dendrit
cell
accordingli
hybrid
phage
vaccin
directli
deliv
antigenencod
sequenc
immunoreact
cell
affin
matur
perform
sever
round
librari
generationmutagenesi
select
select
enrich
highaffin
antigenspecif
ligand
secondgener
librari
sgl
implement
screen
lower
concentr
target
antigen
shorter
incub
time
longer
extens
wash
step
display
mutagen
molecul
lower
valenc
phage
particl
establish
sgl
reli
introduc
mutat
nucleotid
sequenc
encod
origin
select
binder
sever
methodolog
avail
purpos
mutagenesi
method
gener
fall
two
categori
sitespecif
random
mutagenesi
sitespecif
mutagenesi
perform
sitedirect
mutagenesi
cassett
mutagenesi
random
mutagenesi
achiev
errorpron
pcr
dna
shuffl
also
nextgener
sequenc
ng
recent
gain
popular
phage
display
tradit
approach
phage
display
screen
reli
multipl
round
affin
select
follow
standard
sanger
sequenc
sanger
sequenc
laborintens
lowthroughput
result
sequenc
insert
limit
number
phage
clone
repres
complet
sequenc
space
librari
also
repeat
round
select
might
lead
small
sampl
space
domin
nonspecif
bind
sequenc
faster
amplif
rate
known
parasit
sequenc
bind
capac
compon
screen
system
particular
plastic
surfac
solid
support
context
final
outcom
isol
fals
posit
hit
actual
specif
bind
target
end
biopan
ng
provid
possibl
character
sequenc
read
singl
run
furthermor
highthroughput
character
divers
bind
variant
perform
earlier
round
biopan
round
select
desir
target
amplif
perform
select
round
enhanc
risk
introduc
biolog
bia
collaps
librari
divers
reduc
number
amplif
round
incorpor
ng
platform
phage
display
screen
decreas
chanc
isol
nonspecif
fals
posit
clone
acceler
process
targetspecif
ligand
identif
beyond
doubt
phage
display
bypass
barrier
way
vaccin
product
abl
resolv
problem
might
face
effort
gener
ideal
vaccin
howev
crystalclear
power
methodolog
offer
wide
varieti
appropri
key
unlock
door
ahead
current
situat
promis
bright
futur
differ
phagebas
vaccin
platform
argu
role
phage
display
continu
grow
come
year
ongo
progress
made
exploit
phage
epitop
map
antigen
present
research
commun
hope
find
new
tactic
strategi
vaccin
discoveri
develop
